The combined result is improved glucose control and reduced calorie intake, resulting in weight loss
It simply means staying aware
Back Nauck, MA, Klein, N, rskov, C, et al (Aug 1993) 'Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients', Diabetologia , 36/8, 741-4
The simplified comparison is this: Semaglutide: GLP-1 receptor activity Tirzepatide: GIP and GLP-1 receptor activity Retatrutide: GIP, GLP-1, and glucagon receptor activity under clinical investigation More receptor activity does not automatically mean a medication is better for every patient
High-risk individuals, such as those suffering from severe GI diseases, pancreatitis, or diabetic retinopathy in the past, should consult a healthcare professional prior to using retatrutide